WHO ICTRP trial
Liver perfusion measurement using PCD-CT to characterize and evaluate the…
DRKS00031822 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00031822 |
|---|---|
| Public title | Liver perfusion measurement using PCD-CT to characterize and evaluate the response to treatment of hepatocellular carcinomas of the liver as part of routine CT diagnostics and comparison with MRI liver diagnostics |
| Scientific title | Liver perfusion measurement using PCD-CT to characterize and evaluate the response to treatment of hepatocellular carcinomas of the liver as part of routine CT diagnostics and comparison with MRI liver diagnostics |
| Primary sponsor | Universitätsklinik Tübingen |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | K74.6;Other and unspecified cirrhosis of liver;K74.6 |
| Interventions | Group 1: Possible study participants are patients who, due to known cirrhosis of the liver, undergo CT diagnostics to clarify a nodule, e.g are compatible in terms of inclusion and exclusion criteria. |
| Registration date | May 15, 2023 |
| Target size | 100 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: